Levofloxacin
Product Images NDC 17478-107

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 17478-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lev0d 0010 01

FDA Label Image

Lev0d 0010 02

FDA Label Image

Lev0d 0010 03

FDA Label Image

Lev0d 0010 04

Lev0d 0010 04
This is a medication guide for Levofloxacin Injection, which requires further dilution before intravenous administration. It is a single-dose vial which should not be directly infused. The guide provides directions for preparation, stability, storage, compatibility, and usual adult dosage. The medication should be stored at 20° to 25°C and protected from light. Unused portions should be discarded. This medication is manufactured by Akorn, Inc. in Lake Forest, IL. Pharmacists are advised to dispense the medication guide to each patient. NDC 17478-107-20 is mentioned on the label along with dosage information.*
FDA Label Image

Lev0d 0010 05

Lev0d 0010 05
This is a medication guide for Levofloxacin Injection with a strength of 500 mg/20 mL (25 mg/mL) intended for intravenous infusion. A further dilution is required for the medication to be administered effectively. The accompanying medication guide should be dispensed to each patient. Each vial contains Levofloxacin 500 mg as the active ingredient along with other inactive ingredients such as diluted hydrochloric acid, NF and sodium hydroxide, NF for pH adjustments. The pH range for the solution is from 3.8 to 5.8. The manufacturer of the medication is Ao, nc. Lake Forst, L 60045. The vial contents are not intended for direct infusion and must be further diluted with an appropriate solution prior to intravenous administration. The insert provides information on the preparation of intravenous solutions, stability, storage, compatibility, and the usual adult dosage. The medication should be stored at 20°C to 25°C [see USP Controlled Room Temperature] and should be protected from light. Any unused portion should be discarded, and the medication should be retained in the carton until the time of use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.